Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study

Oesophagogastric (OG) cancer is a highly lethal disease requiring novel treatment options. c-MYC and/or HER-2 amplified oesophageal cancer models have demonstrated sensitivity to BTK inhibition with ibrutinib. We evaluated the safety and efficacy of ibrutinib in patients with c-MYC and/or HER2 ampli...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Fiona Turkes, Annette Bryant, Ruwaida Begum, Michael Davidson, Eleftheria Kalaitzaki, Maria Aresu, Retchel Lazaro-Alcausi, Jane Bryant, Isma Rana, Sue Chua, Lauren Aronson, Sanna Hulkki-Wilson, Charlotte Fribbens, David Watkins, Sheela Rao, Naureen Starling, David Cunningham, Irene Y. Chong, Ian Chau
格式: Artigo
語言:Inglês
出版: MDPI AG 2022-03-01
叢編:Current Oncology
主題:
oesophagogastric cancer
HER2
c-MYC
ibrutinib
在線閱讀:https://www.mdpi.com/1718-7729/29/4/176
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍